Avere Solves VMware Storage Problem

Avere Systems, Inc. announced that Concert Pharmaceuticals, Inc., a
clinical stage biotechnology company, has implemented its FXT Series Edge
filers into its existing storage infrastructure.

The Avere Edge filers were chosen to reduce latency and improve performance of
applications in Concert’s mission.

Lexington, MA-based Concert is dedicated to creating new medicines through
its proprietary DCE Platform that utilizes the naturally occurring element
deuterium – a safe and stable form of the element hydrogen. It uses
deuterium to improve upon the metabolic properties of a drug while making
little or no change to its intrinsic effectiveness. Concert has executed on
this approach with its program, CTP-499, in Phase 2 clinical testing for
chronic kidney disease.

Concert operates in a nearly 100% virtualized environment, including Exchange
and application servers, with a filer from NetApp. With the NetApp filer
nearing its end of life and issues of unpredictable traffic spikes, Concert
began looking at new storage options that would minimize disruption to its
production environment and allow it to keep its existing filer. The
organization decided to implement a pair of Avere FXT Series Edge filers to
optimize its environment and run all of its VMware traffic through.

"Basically, what drove me to Avere
was a ‘bursty’ pattern of storage use that required me to schedule and plan the
clock cycles throughout the day," said K. Mitch Goldenberg, associate
director of IT/IS at Concert Pharmaceuticals. "I put Avere in front of everything to flatten out the spikes. And it
works beautifully. It absorbs the ‘burstiness’ and gives low latency,
predictable ops per second to my Core filer. So, now I can go and speed up what
I was already doing."

Avere recently introduced its Edge-Core architecture for NAS that ensures
enterprise IT is best positioned to leverage the performance benefits of flash,
the consolidation benefits of virtualization and the collaborative and economic
benefits of the cloud. The new architecture for NAS puts the fastest media and
the intelligence to manage it closest to the user, boosting performance and
removing storage bottlenecks created by legacy NAS architectures.

"For a company like Concert
Pharmaceuticals that wants to simultaneously leverage its existing infrastructure
and solve a storage performance problem, Avere is a perfect fit," said
Ron Bianchini, co-founder and CEO of Avere Systems. "Avere FXT Series Edge filers are an ideal storage solution for
virtualized environments because of their ability to provide the simplicity and
familiarity of NAS with the ability to handle the write-centric workloads that
virtualization generates."